Buch, Englisch, Band 807, 119 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 3317 g
First International Conference (ICIDN - 2012), Dec. 15-18, 2012, Kathmandu, Nepal
Buch, Englisch, Band 807, 119 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 3317 g
Reihe: Advances in Experimental Medicine and Biology
ISBN: 978-81-322-1776-3
Verlag: Springer India
The book addresses the interdisciplinary scientific approach for the systemic understanding of connections between major human diseases and their treatment regime by applying the tools and techniques of nanotechnology. It also highlights the interdisciplinary collaborative researches for innovation in Biomedical Sciences. The book is a first volume which presents collection of best papers presented in the First International Conference on Infectious Diseases and Nanomedicine held during Dec. 15-18, 2012 in Kathmandu, Nepal. The book focuses mainly on the topics: emerging infectious diseases; antimicrobial agents, vaccines and immunity; drug design, drug delivery and tissue engineering and nanomaterials and biomedical materials.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Infektionskrankheiten
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Biomedizin, Medizinische Forschung, Klinische Studien
- Naturwissenschaften Chemie Chemie Allgemein Pharmazeutische Chemie, Medizinische Chemie
Weitere Infos & Material
Auger-architectomics: Introducing a New Nanotechnology to Infectious Disease.- Rational Design of Antigens to Improve the Sero-diagnosis of Tick-borne Borreliosis in Central Regions of Russia.- Ayurvedic Bhasmas: Overview on Nanomaterialistic Aspects, Applications and Perspectives.- Nanobiosensors: Role in Cancer Detection and Diagnosis.- Cell Compatible Arginine Containing Cationic Polymer: One-pot Synthesis and Preliminary Biological Assessment.- Neuroinvasive and Neurotropic Human Respiratory Coronaviruses: Potential Neurovirulent Agents in Humans.- Bacteriophages as Potential Treatment Option for Antibiotic Resistant Bacteria.